PRVA vs. HIMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, WGS, and VCYT
Should you be buying Privia Health Group stock or one of its competitors? The main competitors of Privia Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.
Privia Health Group vs. Its Competitors
Hims & Hers Health (NYSE:HIMS) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.
Hims & Hers Health has higher earnings, but lower revenue than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 10.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Hims & Hers Health has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.
Hims & Hers Health presently has a consensus price target of $39.58, indicating a potential downside of 21.24%. Privia Health Group has a consensus price target of $28.38, indicating a potential upside of 38.83%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.
Hims & Hers Health has a net margin of 9.24% compared to Privia Health Group's net margin of 0.87%. Hims & Hers Health's return on equity of 22.75% beat Privia Health Group's return on equity.
In the previous week, Hims & Hers Health had 75 more articles in the media than Privia Health Group. MarketBeat recorded 79 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.43 beat Hims & Hers Health's score of 0.28 indicating that Privia Health Group is being referred to more favorably in the news media.
Summary
Hims & Hers Health beats Privia Health Group on 9 of the 17 factors compared between the two stocks.
Get Privia Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Privia Health Group Competitors List
Related Companies and Tools
This page (NASDAQ:PRVA) was last updated on 7/16/2025 by MarketBeat.com Staff
Free PRVA Stock Alerts